Codagenix, Inc   Report issue

For profit Phase 1
Founded: Stony Brook NY United States (2011)

Organization Overview

First Clinical Trial
2017
NCT03926416
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Codagenix, Inc